Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2008-07-01
2008-07-01
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C530S300000, C530S350000, C424S009100, C424S009200, C424S184100, C424S185100, C424S190100, C424S234100
Reexamination Certificate
active
07393539
ABSTRACT:
A method is provided for identifying mycobacterial genes that are induced or up-regulated under continuous culture conditions defined by a dissolved oxygen tension of up to 10% air saturation measured at 37° C. when compared with a dissolved oxygen tension of at least 40% air saturation measured at 37° C. Said induced or up-regulated genes form the basis of nucleic acid vaccines, or provide targets to allow preparation of attenuated mycobacteria for vaccines against mycobacterial infections. Similarly, peptides encoded by said induced or up-regulated genes are employed in vaccines. In a further embodiment, the identified genes/peptides provide the means for identifying the presence of a mycobacterial infection in a clinical sample by nucleic acid probe or antibody detection.
REFERENCES:
patent: 5876991 (1999-03-01), DeHoff et al.
patent: 5998194 (1999-12-01), Summers et al.
patent: 6572865 (2003-06-01), Nano
patent: 2000-508525 (2000-07-01), None
Daniel, T.M., “Soluble Mycobacterial Antigens”, in, The Mycobacteria, a sourcebook, Part A, eds. Kubica and Wayne, marcel Dekker, Inc., New York, pp. 417-466, 1984.
Stedman's Medical Dictionary, 26thedition, Williams & Wilkins, Baltimore MD, 1995. p. 868.
Boon, C. et al., “Proteins ofMycobacterium bovisBCG Induced in the Wayne Dormancy Model,”J. Bacteriol. 183:2672-2676, American Society for Microbiology (Apr. 2001).
Cunningham, A.F. and Spreadbury, C.L., “Mycobacterial Stationary Phase Induced by Low Oxygen Tension: Cell Wall Thickening and Localization of the 16-Kilodalton α-Crystallin Homolog,”J. Bacteriol. 180:801-808, American Society for Microbiology (1998).
Cole, S.T. et al., “Deciphering the biology ofMycobacterium tuberculosisfrom the complete genome sequence,”Nature 393:537-544, Macmillan Publishers Ltd. (1998).
James, B.W. et al., “The physiology and pathogenicity ofMycobacterium tuberculosisgrown under controlled conditions in a defined medium,”J. Appl. Microbiol. 88:669-677, The Society for Applied Microbiology (Apr. 2000).
Murugasu-Oei, B. et al., “Upregulation of stress response genes and ABC transporters in anaerobic stationary-phaseMycobacterium smegmatis,” Mol. Gen. Genet. 262:677-682, Springer-Verlag (1999).
Sherman, D.R. et al., “Regulation of theMycobacterium tuberculosishypoxic response gene encoding α-crystallin”Proc. Natl. Acad. Sci. 98:7534-7539, The National Academy of Sciences (Jun. 19, 2001).
Yuan, Y. et al., “The 16-kDa α-crystallin (Acr) protein ofMycobacterium tuberculosisis required for growth in macrophages,”Proc. Natl. Acad. Sci. 95:9578-9583, The National Academy of Sciences (1998).
EMBL Database Accession No. Z75555, Cole, S.T. et al., “Mycobacterium tuberculosisH37Rv complete genome; segment 60/162,” (Jun. 30, 1996).
Bacon, J., et al., “The influence of reduced oxygen availability on pathogenicity and gene expression inMycobacterium tuberculosis,” Tuberculosis 4:205-217, Elsevier Ltd. (Aug. 2004).
Chaitra, et al., “Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins ofMycobacterium tuberculosisby the Ribi adjuvant,”Vaccine 25:7168-7176, Elsevier Ltd. (2007).
Ramakrishnan, L., et al., “Granuloma-Specific Expression of Mycobacterium Virulence Proteins from the Glycine-Rich PE-PGRS Family,”Science 288:1436-1439, American Association for the Advancement of Science (May 2000).
Vipond, et al., “Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge,”Vaccine 24:6340-6350, Elsevier Ltd. (2006).
Dialog file 351, Accession No. 8374384, WPI English language abstract for JP 2000-508525 (listed on accompanying form PTO/SB/08A as document FP1).
European Search Report for European Application No. 02747549, mailed Jan. 10, 2008, European Patent Office, Munich, DE.
Database Uniprot, Accession No. O53247, “Possible Conserved Transmembrane Protein,” 4 pages (first available 1998).
Database EMBL, Accession No. Z97188, “Mycobacterium tuberculosisH37Rv complete genome; segment 158/162,” 20 pages (1998).
Database EMBL, Accession No. AL021287, “Mycobacterium tuberculosisH37Rv complete genome; segment 132/162,” 50 pages (1999).
Bacon Joanna
James Brian William
Marsh Philip
Health Protection Agency
Sterne Kessler Goldstein & Fox P.L.L.C.
Swartz Rodney P
LandOfFree
Mycobacterial antigens expressed under low oxygen tension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycobacterial antigens expressed under low oxygen tension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterial antigens expressed under low oxygen tension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2763647